Short-term Effects Kinesiotaping (KT) on Balance and Gait in Parkinson's Disease (DP) (KT-DP)

March 26, 2020 updated by: University of Castilla-La Mancha
To analyze the short-term effect of kinesiotaping in balance and gait on Parkinson's disease

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Toledo, Spain, 45006
        • Javier Merino Andrés

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of stage III PD, according to the Hoehn and Yahr scale.
  • Subjects who are in the age range of 50 to 80 years.
  • Acceptance of informed consent.
  • Not present a musculoskeletal disorder or other neurological disease that interferes with balance and / or walking.
  • Not having a diagnosed vestibular disorder.

Exclusion Criteria:

  • Diagnosis of parkinsonism o Parkison-Like.
  • Taking medications that may interfere with the different variables evaluated.
  • Allergy to any component of the bandage.
  • Being a pacemaker.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Kinesiotaping Group
We used kinesiotaping (gastrocnemius and lumbar back) plus exercise
Other: Kinesiotaping
We used kinesiotaping in gastrocnemius and lumbar back
Active Comparator: Exercise Group
We used only exercise
Other: Exercise
Exercises about balance and gait

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg Test - T0
Time Frame: up to week
Berg Test pre-intervention
up to week
Berg Test - T1
Time Frame: up to week
Berg Test post-intervention two days
up to week
Berg Test - T2
Time Frame: up to week
Berg Test post-intervention seven days
up to week
Tinetti Gait Test - T0
Time Frame: up to week
Tinetti Gait Test pre-intervention
up to week
Tinetti Gait Test - T1
Time Frame: up to week
Tinetti Gait Test post-intervention two days
up to week
Tinetti Gait Test - T2
Time Frame: up to week
Tinetti Gait Test post-intervention seven days
up to week
Up & Go Test - T0
Time Frame: up to week
Up & Go Test pre-intervention
up to week
Up & Go Test - T1
Time Frame: up to week
Up & Go Test post-intervention two days
up to week
Up & Go Test - T2
Time Frame: up to week
Up & Go Test post-intervention seven days
up to week
Parkinson's Disease Questionnaire - T0
Time Frame: up to month
Parkinson's Disease Questionnaire pre-intervention
up to month
Parkinson's Disease Questionnaire - T1
Time Frame: up to month
Parkinson's Disease Questionnaire post-intervention
up to month
surface electromyography -T0
Time Frame: up to week
surface electromyography pre-intervention
up to week
surface electromyography -T1
Time Frame: up to week
surface electromyography post-intervention two days
up to week
surface electromyography -T2
Time Frame: up to week
surface electromyography post-intervention seven days
up to week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Castilla-La Mancha

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 1, 2020

Primary Completion (Anticipated)

August 1, 2020

Study Completion (Anticipated)

August 1, 2020

Study Registration Dates

First Submitted

March 24, 2020

First Submitted That Met QC Criteria

March 26, 2020

First Posted (Actual)

March 30, 2020

Study Record Updates

Last Update Posted (Actual)

March 30, 2020

Last Update Submitted That Met QC Criteria

March 26, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • jma002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Kinesiotaping

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe